硼替佐米用于复发多发性骨髓瘤的安全性及有效性 - Suppr

The safety and efficacy of bortezomib in relapsed multiple myeloma.

作者信息

Jagannath Sundar

机构信息

Multiple Myeloma Service and Bone Marrow and Blood Stem Cell Transplantation Center, Saint Vincent's Comprehensive Cancer Center, New York City, NY, and New York Medical College, USA.

出版信息

Clin Adv Hematol Oncol. 2006 May;4(5):2-3; discussion 8; suppl 13.

PMID:16830423

Abstract

摘要

相似文献

The safety and efficacy of bortezomib in relapsed multiple myeloma.

Clin Adv Hematol Oncol. 2006 May;4(5):2-3; discussion 8; suppl 13.

Optimizing bortezomib treatment in patients with relapsed multiple myeloma.

Clin Adv Hematol Oncol. 2006 May;4(5):4-5; discussion 8; suppl 13.

Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors.

Clin Lymphoma Myeloma. 2009 Aug;9(4):302-6. doi: 10.3816/CLM.2009.n.059.

[Effectiveness of bortezomib and bortezomib-containing programs for the treatment of recurrent and resistant multiple myeloma].

Ter Arkh. 2010;82(7):57-61.

Retreatment with bortezomib alone or in combination for patients with multiple myeloma following an initial response to bortezomib.

Am J Hematol. 2009 Oct;84(10):657-60. doi: 10.1002/ajh.21517.

Bortezomib plus melphalan and prednisone for multiple myeloma.

N Engl J Med. 2008 Dec 11;359(24):2613; author reply 2613-4.

Updated survival analyses after prolonged follow-up of the phase 2, multicenter CREST study of bortezomib in relapsed or refractory multiple myeloma.

Br J Haematol. 2008 Nov;143(4):537-40. doi: 10.1111/j.1365-2141.2008.07359.x. Epub 2008 Sep 6.

Phase I/II trial assessing bortezomib and melphalan combination therapy for the treatment of patients with relapsed or refractory multiple myeloma.

J Clin Oncol. 2006 Feb 20;24(6):937-44. doi: 10.1200/JCO.2005.03.2383. Epub 2006 Jan 17.

Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma.

Br J Haematol. 2009 Mar;144(6):887-94. doi: 10.1111/j.1365-2141.2008.07572.x. Epub 2009 Jan 12.

Management of multiple myeloma with bortezomib: experts review the data and debate the issues.

Oncology. 2006;70(6):474-82. doi: 10.1159/000099284. Epub 2007 Feb 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The safety and efficacy of bortezomib in relapsed multiple myeloma.

作者信息

Jagannath Sundar

机构信息

Multiple Myeloma Service and Bone Marrow and Blood Stem Cell Transplantation Center, Saint Vincent's Comprehensive Cancer Center, New York City, NY, and New York Medical College, USA.